The researchers have discovered that the increase in microvascular complications in individuals who have type 2 diabetes ...

New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...

The mechanisms driving the cardiovascular and renal benefits of therapies targeting intestinal hormones in type 2 diabetes ...

Israel: A recent study published in the Journal of Diabetes and its Complications has drawn attention to the significant ...

See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!

The health of the heart, kidneys, and the body's metabolism are all connected. It is, therefore, extremely important to ...

The field of cardiometabolic health has garnered substantial attention due to the increasing prevalence of type 2 diabetes ...

Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

Diabetes remains a serious chronic disease worldwide, affecting approximately 589 million people 3 and often accompanied by cardiovascular complications. 4 People with Type 1 and Type 2 diabetes ...

Researchers analyzed hospital inpatient data to evaluate the risk for vascular events on the basis of PCOS among women with ...

The researchers plan to continue investigating adult-onset type 1 diabetes, including risk factors for developing the disease and the prognosis of other outcomes, such as microvascular complications.